TY - JOUR
T1 - Fabrication of highly uniform gel coatings by the conversion of surface-anchored metal-organic frameworks
AU - Tsotsalas, Manuel
AU - Liu, Jinxuan
AU - Tettmann, Beatrix
AU - Grosjean, Sylvain
AU - Shahnas, Artak
AU - Wang, Zhengbang
AU - Azucena, Carlos
AU - Addicoat, Matthew
AU - Heine, Thomas
AU - Lahann, Joerg
AU - Overhage, Jörg
AU - Bräse, Stefan
AU - Gliemann, Hartmut
AU - Wöll, Christof
PY - 2014/1/8
Y1 - 2014/1/8
N2 - We report the fabrication of 3D, highly porous, covalently bound polymer films of homogeneous thickness. These surface-bound gels combine the advantages of metal-organic framework (MOF) materials, namely, the enormous flexibility and the large size of the maximum pore structures and, in particular, the possibility to grow them epitaxially on modified substrates, with those of covalently connected gel materials, namely, the absence of metal ions in the deposited material, a robust framework consisting of covalent bonds, and, most importantly, pronounced stability under biological conditions. The conversion of a SURMOF (surface-mounted MOF) yields a surface-grafted gel. These SURGELs can be loaded with bioactive compounds and applied as bioactive coatings and provide a drug-release platform in in vitro cell culture studies.
AB - We report the fabrication of 3D, highly porous, covalently bound polymer films of homogeneous thickness. These surface-bound gels combine the advantages of metal-organic framework (MOF) materials, namely, the enormous flexibility and the large size of the maximum pore structures and, in particular, the possibility to grow them epitaxially on modified substrates, with those of covalently connected gel materials, namely, the absence of metal ions in the deposited material, a robust framework consisting of covalent bonds, and, most importantly, pronounced stability under biological conditions. The conversion of a SURMOF (surface-mounted MOF) yields a surface-grafted gel. These SURGELs can be loaded with bioactive compounds and applied as bioactive coatings and provide a drug-release platform in in vitro cell culture studies.
UR - http://www.scopus.com/inward/record.url?scp=84892150565&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892150565&partnerID=8YFLogxK
U2 - 10.1021/ja409205s
DO - 10.1021/ja409205s
M3 - Article
C2 - 24328287
AN - SCOPUS:84892150565
SN - 0002-7863
VL - 136
SP - 8
EP - 11
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 1
ER -